Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
The Emergence of Multi-Modal Real-World Data: The Power of Clinico-Genomic Data Versus Traditional RWD Sources

Request Your Free White Paper Now:

"The Emergence of Multi-Modal Real-World Data: The Power of Clinico-Genomic Data Versus Traditional RWD Sources"

This white paper from NeoGenomics explores the potential of clinico-genomic data to revolutionize healthcare by guiding drug development and therapeutic interventions, highlighting the superiority of clinico-genomic data over traditional real-world data sources, which mainly consist of electronic medical records and medical claims.

The shift toward precision medicine in drug discovery and clinical development underscores the importance of multi-modal real-world data (RWD). Traditional RWD sources often lack detailed biomarker data, crucial for developing targeted therapies for complex diseases. Recent FDA guidelines and advancements in data-linking technologies have enabled the integration of clinical and genomic data, providing a more comprehensive view of patients' health and treatment responses. This integration facilitates more precise clinical trial designs and could significantly improve patient outcomes by enabling the development of personalized therapies. Multi-modal data also allow for population-scale studies and deeper insights into disease mechanisms and treatment efficacy.


Offered Free by: NeoGenomics
See All Resources from: NeoGenomics

Recommended for Professionals Like You: